Editas Medicine, Inc.
EDIT
$2.83
$0.165.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.58M | 4.66M | 30.60M | 61.00K | 513.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.58M | 4.66M | 30.60M | 61.00K | 513.00K |
| Cost of Revenue | 16.18M | 26.59M | 48.61M | 47.64M | 54.21M |
| Gross Profit | -12.60M | -21.94M | -18.01M | -47.58M | -53.70M |
| SG&A Expenses | 12.86M | 13.38M | 16.35M | 18.09M | 18.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.04M | 39.97M | 64.97M | 65.73M | 72.42M |
| Operating Income | -25.46M | -35.31M | -34.36M | -65.67M | -71.90M |
| Income Before Tax | -53.24M | -76.09M | -45.40M | -62.14M | -67.61M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -53.24M | -76.09M | -45.40M | -62.14M | -67.61M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.24M | -76.09M | -45.40M | -62.14M | -67.61M |
| EBIT | -25.46M | -35.31M | -34.36M | -65.67M | -71.90M |
| EBITDA | -23.63M | -33.39M | -32.98M | -64.07M | -70.48M |
| EPS Basic | -0.63 | -0.92 | -0.55 | -0.75 | -0.82 |
| Normalized Basic EPS | -0.20 | -0.27 | -0.25 | -0.47 | -0.51 |
| EPS Diluted | -0.63 | -0.92 | -0.55 | -0.75 | -0.82 |
| Normalized Diluted EPS | -0.20 | -0.27 | -0.25 | -0.47 | -0.51 |
| Average Basic Shares Outstanding | 84.41M | 83.06M | 82.61M | 82.49M | 82.31M |
| Average Diluted Shares Outstanding | 84.41M | 83.06M | 82.61M | 82.49M | 82.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |